Ipilimumab et ses dérivés pharmaceutiquement acceptables (YERVOY®)
- 专利权人:
- MEDAREX INC.
- 发明人:
- 申请号：
- LU91928
- 公开号：
- LU91928I2
- 申请日:
- 2012.01.09
- 申请国别(地区):
- LU
- 年份:
- 2012
- 代理人:
- 摘要：
- The present invention provides novel human sequence antibodies against human CTLA-4 and methods of treating human diseases, infections and other conditions using these antibodies.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- ARTIFICIAL ANTIGEN PRESENTING CELLS FOR GENETIC ENGINEERING OF IMMUNE CELLS
- ANTICORPS À DOMAINE UNIQUE ET SES VARIANTS CONTRE CTLA-4
- ENHANCING THE EFFECT OF CAR ENGINEERED T CELLS BY MEANS OF NUCLEIC ACID VACCINATION
- Nouveau peptide antigène du mélanome et ses utilisations
- CD19-SPECIFIC CHIMERIC ANTIGEN RECEPTOR AND USE THEREOF
